Iinuma Yoshitsugu
Department of Clinical Laboratory, Kyoto University Hospital, Kyoto.
Rinsho Byori. 2008 Jan;56(1):36-45.
Measles is a highly contagious disease characterized by a prodromal illness of fever, coryza, cough, and conjunctivitis followed by the appearance of a generalized maculopapular rash. Despite the availability of an effective and safe live attenuated vaccine, measles remains a cause of continuing outbreaks in Japan. Measles often accompanies diverse complications, including pneumonitis, otitis media, and central nervous system involvement. Neurological complications of measles includes ADEM, MIBE, and SSPE. MIBE and SSPE have unfavorable prognosis, which are caused by persistent infection of particular mutants of measles virus (MV) in brain. In SSPE patients, measles antibody titer increase in cerebrospinal fluid and serum. Primary vaccine failure and secondary vaccine failure may be a major cause of outbreaks in Japan, therefore, promotion of vaccination should be emphasized. 2 doses vaccination methods began in Japan in 2006, and supplementary vaccination program at 12 and 18 years old begins from 2008. Protection level of antibody titer varies according to the antibody measurement methods. NT provides the best correlate for protection from infection, however, needs complicated procedure. PA is chosen for the surveillance method in Japan, and 1:128 or over seems protection level. To protect health-care associated infection of MV, all health care worker under 35 years old should be vaccinated if not have adequate immunity.
麻疹是一种高度传染性疾病,其特征为前驱期出现发热、鼻炎、咳嗽和结膜炎,随后出现全身性斑丘疹。尽管有有效且安全的减毒活疫苗,但麻疹仍是日本持续爆发疫情的原因之一。麻疹常伴有多种并发症,包括肺炎、中耳炎和中枢神经系统受累。麻疹的神经系统并发症包括急性播散性脑脊髓炎(ADEM)、麻疹包涵体脑炎(MIBE)和亚急性硬化性全脑炎(SSPE)。MIBE和SSPE预后不良,是由麻疹病毒(MV)的特定突变体在脑中持续感染所致。在SSPE患者中,脑脊液和血清中的麻疹抗体滴度会升高。原发性疫苗失败和继发性疫苗失败可能是日本疫情爆发的主要原因,因此,应强调推广疫苗接种。2剂次接种方法于2006年在日本开始实施,2008年起开始针对12岁和18岁人群开展补充疫苗接种计划。抗体滴度的保护水平因抗体检测方法而异。中和试验(NT)对预防感染的相关性最佳,但操作过程复杂。血凝抑制试验(PA)被选为日本的监测方法,1:128及以上似乎是保护水平。为防止与麻疹相关的医疗保健感染,所有35岁以下且无足够免疫力 的医护人员均应接种疫苗。